[1] Liu H, Fu Y, Wang K P. Asthma and risk of coronary heart disease: a meta-analysis of cohort studies[J]. Ann Allergy Asthma Immunol, 2017, 118(6): 689-695. [2] Aurora R N, Crainiceanu C, Gottlieb D J, et al. Obstructive sleep apnea during REM sleep and cardiovascular disease[J]. Am J Respir Crit Care Med, 2018, 197(5): 653-660. [3] 中华医学会呼吸病学分会哮喘学组. 支气管哮喘防治指南(2020年版)[J]. 中华结核和呼吸杂志, 2020, 43(12): 1023-1048. [4] 中华医学会心血管病学分会介入心脏病学组, 中华医学会心血管病学分会动脉粥样硬化与冠心病学组, 中国医师协会心血管内科医师分会血栓防治专业委员会, 等. 稳定性冠心病诊断与治疗指南[J]. 中华心血管病杂志, 2018, 46(9): 680-694. [5] Hopps E, Caimi G. Obstructive sleep apnea syndrome: links betwen pathophysiology and cardiovascular complications[J]. Clin Invest Med, 2015, 38(6): E362-E370. [6] Peker Y, Carlson J, Hedner J. Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up[J]. Eur Respir J, 2006, 28(3): 596-602. [7] Ahmad M, Makati D, Akbar S. Review of and updates on hypertension in obstructive sleep apnea[J]. Int J Hypertens, 2017, 2017: 1848375. [8] Barros D, García-Río F. Obstructive sleep apnea and dyslipidemia: from animal models to clinical evidence[J]. Sleep, 2019, 42(3): zsy236. [9] Sanz-Rubio D, Khalyfa A, Qiao Z H, et al. Cell-selective altered cargo properties of extracellular vesicles following in vitro exposures to intermittent hypoxia[J]. Int J Mol Sci, 2021, 22(11): 5604. [10] Lin X, Chen G P, Qi J C, et al. Effect of continuous positive airway pressure on arterial stiffness in patients with obstructive sleep apnea and hypertension: a meta-analysis[J]. Eur Arch Otorhinolaryngol, 2016, 273(12): 4081-4088. [11] Kent B D, McNicholas W T, Ryan S. Insulin resistance, glucose intolerance and diabetes mellitus in obstructive sleep apnoea[J]. J Thorac Dis, 2015, 7(8): 1343-1357. [12] 魏嘉洁, 矫杰,周迎生.2型糖尿病合并阻塞性睡眠呼吸暂停综合征的临床特征及其危险因素[J].首都医科大学学报,2020,41(1):35-39. [13] Chung W S, Shen T C, Lin C L, et al. Adult asthmatics increase the risk of acute coronary syndrome: a nationwide population-based cohort study[J]. Eur J Intern Med, 2014, 25(10): 941-945. [14] Magnussen H, Watz H. Systemic inflammation in chronic obstructive pulmonary disease and asthma: relation with comorbidities[J]. Proc Am Thorac Soc, 2009, 6(8): 648-651. [15] Ilmarinen P, Tuomisto L E, Niemelä O, et al. Comorbidities and elevated IL-6 associate with negative outcome in adult-onset asthma[J]. Eur Respir J, 2016, 48(4): 1052-1062. [16] Ciavarella D, Tepedino M, Chimenti C, et al. Correlation between body mass index and obstructive sleep apnea severity indexes - a retrospective study[J]. Am J Otolaryngol, 2018, 39(4): 388-391. [17] Isono S. Obesity and obstructive sleep apnoea: mechanisms for increased collapsibility of the passive pharyngeal airway[J]. Respirology, 2012, 17(1): 32-42. [18] 吴晓峰, 胡克.经皮电刺激颏舌肌治疗阻塞性睡眠呼吸暂停研究进展[J].解放军医药杂志,2021,33(10):113-116. [19] Ghandehari H, Le V, Kamal-Bahl S, et al. Abdominal obesity and the spectrum of global cardiometabolic risks in US adults[J]. Int J Obes, 2009, 33(2): 239-248. [20] Can M, Uygur F, Tanr?verdi H, et al. Effect of continuous positive airway pressure (CPAP) therapy on IL-23 in patients with obstructive sleep apnea[J]. Immunol Res, 2016, 64(5/6): 1179-1184. [21] Ciftci T U, Ciftci B, Guven S F, et al. Effect of nasal continuous positive airway pressure in uncontrolled nocturnal asthmatic patients with obstructive sleep apnea syndrome[J]. Respir Med, 2005, 99(5): 529-534. [22] Serrano-Pariente J, Plaza V, Soriano J B, et al. Asthma outcomes improve with continuous positive airway pressure for obstructive sleep apnea[J]. Allergy, 2017, 72(5): 802-812. |